A citation-based method for searching scientific literature

Jeffrey A Rappaport, Scott A Waldman. Front Oncol 2018
Times Cited: 18







List of co-cited articles
110 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
81
22

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
Adam E Snook, Benjamin J Stafford, Peng Li, Gene Tan, Lan Huang, Ruth Birbe, Stephanie Schulz, Matthias J Schnell, Mathew Thakur, Jay L Rothstein,[...]. J Natl Cancer Inst 2008
38
22

Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
K Shailubhai, H H Yu, K Karunanandaa, J Y Wang, S L Eber, Y Wang, N S Joo, H D Kim, B W Miedema, S Z Abbas,[...]. Cancer Res 2000
170
22

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.
Peng Li, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari. Am J Pathol 2007
87
22

The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Chantell Wilson, Jieru E Lin, Peng Li, Adam E Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, Melanie A Girondo, Hallgeir Rui, Terry Hyslop,[...]. Cancer Epidemiol Biomarkers Prev 2014
35
22

Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice.
Bianca N Islam, Sarah K Sharman, Yali Hou, Allison E Bridges, Nagendra Singh, Sangmi Kim, Ravindra Kolhe, Jimena Trillo-Tinoco, Paulo C Rodriguez, Franklin G Berger,[...]. Cancer Prev Res (Phila) 2017
38
16



Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC mice.
Wen-Chi L Chang, Shet Masih, Anusha Thadi, Viren Patwa, Apoorva Joshi, Harry S Cooper, Vaseem A Palejwala, Margie L Clapper, Kunwar Shailubhai. World J Gastrointest Pharmacol Ther 2017
14
21

Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.
F K Hamra, L R Forte, S L Eber, N V Pidhorodeckyj, W J Krause, R H Freeman, D T Chin, J A Tompkins, K F Fok, C E Smith. Proc Natl Acad Sci U S A 1993
296
16


Guanylyl cyclases and signaling by cyclic GMP.
K A Lucas, G M Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz, K P Chepenik, S A Waldman. Pharmacol Rev 2000
905
16

A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
Jason D Whitt, Nan Li, Heather N Tinsley, Xi Chen, Wei Zhang, Yonghe Li, Bernard D Gary, Adam B Keeton, Yaguang Xi, Ashraf H Abadi,[...]. Cancer Prev Res (Phila) 2012
51
16

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
S L Carrithers, M T Barber, S Biswas, S J Parkinson, P K Park, S D Goldstein, S A Waldman. Proc Natl Acad Sci U S A 1996
178
16

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
Scott A Waldman, Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, David S Weinberg. JAMA 2009
84
16

Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
Allison A Aka, Jeff A Rappaport, Amanda M Pattison, Takami Sato, Adam E Snook, Scott A Waldman. Expert Rev Clin Pharmacol 2017
17
17

Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
127
16

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
Glen P Marszalowicz, Adam E Snook, Michael S Magee, Dante Merlino, Lisa D Berman-Booty, Scott A Waldman. Oncotarget 2014
17
17

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Ruth Birbe, Juan P Palazzo, Rhonda Walters, David Weinberg, Stephanie Schulz, Scott A Waldman. Hum Pathol 2005
92
16

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
100
16

Colorectal cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, Stacey A Fedewa, Lynn F Butterly, Joseph C Anderson, Andrea Cercek, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2020
16

Guanylin mRNA expression in human intestine and colorectal adenocarcinoma.
M B Cohen, J A Hawkins, D P Witte. Lab Invest 1998
73
16

Expression of guanylin is downregulated in mouse and human intestinal adenomas.
K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
67
16

Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.
Adam E Snook, Peng Li, Benjamin J Stafford, Elizabeth J Faul, Lan Huang, Ruth C Birbe, Alessandro Bombonati, Stephanie Schulz, Matthias J Schnell, Laurence C Eisenlohr,[...]. Cancer Res 2009
30
16

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
Michael S Magee, Crystal L Kraft, Tara S Abraham, Trevor R Baybutt, Glen P Marszalowicz, Peng Li, Scott A Waldman, Adam E Snook. Oncoimmunology 2016
36
16

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.
Michael S Magee, Tara S Abraham, Trevor R Baybutt, John C Flickinger, Natalie A Ridge, Glen P Marszalowicz, Priyanka Prajapati, Adam R Hersperger, Scott A Waldman, Adam E Snook. Cancer Immunol Res 2018
42
16

APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
Erik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, Babar Bashir, Ellen Caparosa, Jonathan Stem, Adam E Snook, Scott A Waldman. Cancer Biol Ther 2020
5
60

ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice.
Peng Li, Jieru E Lin, Adam E Snook, Scott A Waldman. Toxins (Basel) 2017
9
33

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
John C Flickinger, Jagmohan Singh, Robert Carlson, Elinor Leong, Trevor R Baybutt, Joshua Barton, Ellen Caparosa, Amanda Pattison, Jeffrey A Rappaport, Jamin Roh,[...]. J Immunother Cancer 2020
8
37

Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.
Babar Bashir, Dante J Merlino, Jeffrey A Rappaport, Esteban Gnass, Juan P Palazzo, Ying Feng, Eric R Fearon, Adam E Snook, Scott A Waldman. Hum Pathol 2019
8
37

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
101
16

Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies.
Khaldoun Almhanna, Thea Kalebic, Cristina Cruz, Jason E Faris, David P Ryan, JungAh Jung, Tim Wyant, Adedigbo A Fasanmade, Wells Messersmith, Jordi Rodon. Clin Cancer Res 2016
22
16

Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.
Bo Xiang, Trevor R Baybutt, Lisa Berman-Booty, Michael S Magee, Scott A Waldman, Vitali Y Alexeev, Adam E Snook. J Immunol 2017
22
16

Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
Jieru E Lin, Francheska Colon-Gonzalez, Erik Blomain, Gilbert W Kim, Amanda Aing, Brian Stoecker, Justin Rock, Adam E Snook, Tingting Zhan, Terry M Hyslop,[...]. Cancer Res 2016
38
16

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
Adam E Snook, Trevor R Baybutt, Bo Xiang, Tara S Abraham, John C Flickinger, Terry Hyslop, Tingting Zhan, Walter K Kraft, Takami Sato, Scott A Waldman. J Immunother Cancer 2019
18
16

Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
Adam E Snook, Michael S Magee, Stephanie Schulz, Scott A Waldman. Eur J Immunol 2014
29
16

Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Martin Beaulieu, Marie Desaulniers, Nicolas Bertrand, Réna G Deschesnes, Guillaume Beaudry, Geneviève Garon, Jean-François Haince, Michel Houde, Timothy J Holzer. Diagn Mol Pathol 2010
19
16

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
Khaldoun Almhanna, David Wright, Teresa Macarulla Mercade, Jean-Luc Van Laethem, Antonio Cubillo Gracian, Carmen Guillen-Ponce, Jason Faris, Carolina Muriel Lopez, Richard A Hubner, Johanna Bendell,[...]. Invest New Drugs 2017
16
18

Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
Hadi Danaee, Thea Kalebic, Timothy Wyant, Matteo Fassan, Claudia Mescoli, Feng Gao, William L Trepicchio, Massimo Rugge. PLoS One 2017
18
16

Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
Jean-François Haince, Michel Houde, Guillaume Beaudry, Sylvain L'espérance, Geneviève Garon, Marie Desaulniers, Laurie J Hafer, James I Heald, Stephen Lyle, Steven R Grossman,[...]. J Clin Pathol 2010
29
16

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
97
16

Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.
Kunwar Shailubhai, Vaseem Palejwala, Krishna Priya Arjunan, Sayali Saykhedkar, Bradley Nefsky, John A Foss, Stephen Comiskey, Gary S Jacob, Scott E Plevy. World J Gastrointest Pharmacol Ther 2015
40
16

GUCY2C ligand replacement to prevent colorectal cancer.
Erik S Blomain, Amanda M Pattison, Scott A Waldman. Cancer Biol Ther 2016
10
30

Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.
Kunwar Shailubhai, Stephen Comiskey, John A Foss, Rong Feng, Laura Barrow, Gail M Comer, Gary S Jacob. Dig Dis Sci 2013
64
11

Plecanatide: First Global Approval.
Zaina T Al-Salama, Yahiya Y Syed. Drugs 2017
11
18

Glycosylation of the receptor guanylate cyclase C: role in ligand binding and catalytic activity.
Yashoda Ghanekar, Akhila Chandrashaker, Utpal Tatu, Sandhya S Visweswariah. Biochem J 2004
25
11


Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21.
Nirmalya Basu, Sayanti Saha, Imran Khan, Subbaraya G Ramachandra, Sandhya S Visweswariah. J Biol Chem 2014
33
11

Multiple lineage specific expansions within the guanylyl cyclase gene family.
David A Fitzpatrick, Damien M O'Halloran, Ann M Burnell. BMC Evol Biol 2006
31
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.